MAC Clinical Research

We are proud to release the next video in our corporate series, showcasing MAC Clinical Research’s Early Phase Unit (EPU), an MHRA audited and accredited Phase 1 centre located within and supported by the Manchester University Foundation Trust. What sets us apart? 🌟Unrivaled Participant Recruitment: Our EPU is optimally placed for rapid recruitment in Healthy Volunteer studies, with some 30 universities within a 1-hour commute of the unit. The EPU is also surrounded by our fully owned network of late phase sites, allowing a robust funnel of referred trial participants from a population of over 30 million people. 🏥 Uncompromising Safety: Based on a hospital site, the unit has the advantage of being fully supported 24/7 by the NHS emergency response services. Our Medical Affairs Team oversees the medical monitoring of our trials ensuring patient safety remains our top priority. 👩⚕️ Expert Clinical Team: Our medical and scientific teams work to the highest standards of care and trial execution. Our unit is a Faculty of Pharmaceutical Medicine (FPM) accredited training centre for future FIH Investigators. 🔬 Scientific Excellence: We specialise in complex, adaptive trial designs, including EEG, and pharmacodynamic (PD) parameter studies. It’s also where we house our state-of-the-art laboratory, which offers sample reception, clinical pathology, and bioanalytical services, as well as our in-house dedicated scientific services, where we provide unique, non-routine scientific techniques and assessments. Watch our video here: https://lnkd.in/dZr5M4EG #ClinicalResearch #EarlyPhaseUnit #FirstInHuman #MedicalScience #CRO #ClinicalTrials #ResearchInnovation

We are excited to announce that MAC will be attending the PHUSE EU Connect 2024 conference in Strasbourg, France, from 10 to 14 November! Roxanne McGuire, our Head of Statistical Programming, will be speaking in the Professional Development stream, presenting her session "From Senior Programmer to Head-of-Function: Taking that ‘Leap of Faith’" on Tuesday, 12 November at 16:30 in Marie Curie A Hall. Roxanne’s talk will explore career growth and leadership development, sharing insights valuable to programmers and data professionals at all career stages. Suzan Myuslyumova, SAS Programmer, will attend alongside Roxanne, representing MAC’s dedication to advancing clinical research and fostering professional growth within the industry. Meet our team at PHUSE EU Connect 2024 and learn more about our expertise and innovative approaches to statistical programming: https://lnkd.in/dSc_aH6E #PHUSEEUConnect2024 #ClinicalResearch #Programming #CareerDevelopment #MAC

Ready for your next exciting career opportunity? At MAC Clinical Research, we are committed to the advancement of clinical trials to make an outstanding contribution to human health. We seek talented professionals to join our diverse and dynamic team in the following roles: ➡️ Clinical Research Physician ➡️ Senior Quality Assurance Auditor ➡️ Clinical Trial Assistant ➡️ Data Coordinator ➡️ Receptionist/Administrator ➡️ Senior SAS Programmer If you are passionate about clinical research and are eager to grow within a supportive, progressive organisation, we want to hear from you! Discover more and apply today: https://lnkd.in/dseXXZHy #ClinicalResearchCareers #JoinOurTeam #MACClinicalResearch #HealthcareInnovation

We are excited to announce that Claire Horsgood, Vice President of Operations and Growth, and Jacquie Teera, DPH MPH BSc, Head of Global Clinical Operations, will be representing MAC Clinical Research at the 7th Annual SCOPE Europe: Summit for Clinical Ops Executives in Barcelona, Spain! This premier event brings together over 500 senior executives from across the globe to explore the latest trends in clinical trial innovation and operations. From digital and hybrid trials to new case studies and cutting-edge technologies, SCOPE Europe is the place to be for leaders in clinical research. We look forward to connecting with industry peers and discussing strategies to shape the future of clinical operations excellence. Interested in meeting with us? Reach out to us here: https://lnkd.in/dwjzQnmt #SCOPEEurope #ClinicalOps #ClinicalTrials #MACClinicalResearch #Innovation #Pharma #Biotech

This #NationalPharmacyWeek, we proudly recognise the contributions and achievements of pharmacy professionals worldwide. MAC offers an all-encompassing range of fully in-house pharmaceutical services to support our sponsors’ drug asset development and clinical trial programmes. Our in-house pharmacy provides a comprehensive medicine dispensing service, which extends to patient dosing. Our pharmacy teams ensure correct drug storage, reconciliation, accountability, and safe usage for optimal patient outcomes. We also provide GMP Manufacturing, with aseptic facilities, licenced by the MHRA to manufacture both sterile and non-sterile investigational medicinal products (IMPs). At MAC, our comprehensive approach—covering everything from dispensing and storage to manufacturing and distribution—allows us to meet the unique needs of our sponsors while maintaining the highest standards of quality and safety. Find out more in our pharmaceutical services brochure: https://lnkd.in/dtbKxFuX #PharmaceuticalInnovation #ClinicalResearch #GMPManufacturing #HealthcareExcellence

Today is World Menopause Day, which is held every year on 18th October. This year we want to raise awareness and highlight the support available for improving health and wellbeing for women everywhere. Despite impacting half of the world’s population, menopause is a relatively under-researched and underfunded area. In fact, according to a Harvard article published earlier this year, less than 1 percent of published studies even considered menopause in preclinical models. This gap in research can translate to gaps in women’s health care overall. At MAC, Women’s Health studies is a key area of focus for us. Over the past 5 years, we’ve conducted 3 studies in menopause, specifically on Vasomotor Symptoms. Vasomotor symptoms (VMS) are a group of common symptoms that occur during menopause and perimenopause, including hot flashes, night sweats, palpitations, and migraines. These are often considered the cardinal symptoms of menopause. We remain passionate about supporting more research in this area to help alleviate symptoms that will inevitably impact so many of our world’s population. Read our article which explores how advancements in research could help us better understand menopause here: https://lnkd.in/dAV_45Ci #WorldMenopauseDay #WomensHealth #ClinicalResearch #cro

At MAC Clinical Research, we seek dedicated professionals who are passionate about making a difference in the field of clinical research.   We offer a wide variety of roles, both remotely and on-site. Our opportunities span across medical, scientific, and clinical fields, as well as vital areas such as patient recruitment, business development, project management, biometrics, and clinical monitoring.   Whether you’re an experienced professional or just starting your journey, our recruitment team is here to support you in finding a role that aligns with your skills and passions.    At MAC Clinical Research, we believe every career journey matters, and we are committed to helping you make a meaningful impact in the world of clinical research.    Join us in making a difference, learn more about our current vacancies: https://lnkd.in/dWsiVZiW #MACClinicalResearch #JoinOurTeam #CareerOpportunities #HealthcareInnovation #ClinicalResearchJobs #ClinicalCareers

This week, we focus on Obsessive-Compulsive Disorder (OCD), bringing awareness to this complex disorder and the challenges it poses for millions around the globe. Approximately 1 in 40 adults and 1 in 100 children are affected by OCD, according to the International OCD Foundation. At MAC Clinical Research, we are dedicated to advancing the understanding and treatment of OCD as part of our comprehensive focus on psychiatric disorders. OCD symptoms can include a range of distressing thoughts and compulsive behaviours that can significantly impact daily life. With more than half of our studies focused on Central Nervous System (CNS) conditions, we have conducted numerous research initiatives aimed at developing innovative therapies for mental health disorders including OCD and other related conditions. As we observe OCD Awareness Week, let us unite in supporting those affected by OCD and advocating for continued research and improved treatment options. Contact us today and find out how we can support your study: https://lnkd.in/dK2b5Xw9 #OCDawarenessweek #MentalHealthMatters 

Last week we attended the 12th Annual Outsourcing in Clinical Trials (OCT) Nordics conference in Denmark, where the MAC team had a fantastic time connecting with industry experts and forging new relationships across the EU.   Kayleigh Edwards MSc, Inside Business Scientist, reflected:   "Attending the 12th Annual OCT Nordics conference was a great experience, we were fortunate to reconnect with some familiar faces and had plenty of opportunities to network and make new connections in the EU. We were pleased to discover that the MAC brand is more recognisable, and our profile is growing outside of the UK. It was inspiring to hear and learn from a wide variety of speakers and industry experts to learn about current challenges and cutting-edge developments in the clinical research space.“   We’re excited about the connections made and the opportunities ahead for MAC!   If you’d like to learn more about our services or find out how we can meet your study needs, get in touch with us here: https://lnkd.in/dKnZxfuD    #ClinicalTrials #OCTNordics #Networking #ClinicalResearch #biotech #pharamaceutical

As today marks World Mental Health Day, we want to raise awareness of the growing number of people who are affected by mental health disorders across the globe. According to World Health Organization, approximately 970 million people worldwide are living with a mental health disorder. The Mental Health Foundation projects that by 2030, mental health problems will be the leading cause of mortality and morbidity worldwide. At MAC Clinical Research, we are committed to improving mental health through our expertise in conducting clinical studies in this area. We have vast experience in many mental health disorders including Major Depressive Disorder (MDD), Post-Traumatic Stress Disorder (PTSD), Generalised Anxiety Disorder (GAD), and Treatment-Resistant Depression (TRD). As part of this, we have led numerous psychedelic studies and seen promising results. Our in-house team of experts, including psychiatrists and therapists, have conducted studies using innovative treatments such as psilocybin, ibogaine, and deuterated DMT. These therapies are being explored for their potential in treating conditions like depression and PTSD. Let’s continue to break the stigma and push for progress in mental health treatment and awareness. Find out more about our experience in psychedelics: https://lnkd.in/defpBctQ Contact us to find out how we can support your study: https://lnkd.in/dGFJTbJu #WorldMentalHealthDay #MentalHealthAwareness #ClinicalResearch #PsychedelicResearch #MACClinicalResearch #MentalHealthMatters